MRTX1133
id:
mrtx1133-204-18834009
title:
MRTX1133
text:
MRTX1133 is an investigational drug that targets the G12D mutation in KRAS dependent cancers. It is currently in a phase 1/2 clinical trial for the treatment of solid tumors.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/MRTX1133
date created:
2024-02-18T11:05:29Z
date modified:
2024-09-10T11:11:36Z
main entity:
{"identifier":"Q124735203","url":"https://www.wikidata.org/entity/Q124735203"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/af/MRTX1133.svg","width":166,"height":106}
fields total:
13
integrity:
16